Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$396.76 - $455.92 $511,423 - $587,680
-1,289 Closed
0 $0
Q2 2021

Aug 09, 2021

SELL
$372.36 - $412.07 $262,141 - $290,097
-704 Reduced 35.32%
1,289 $510,000
Q1 2021

May 13, 2021

SELL
$357.26 - $392.57 $138,259 - $151,924
-387 Reduced 16.26%
1,993 $765,000
Q4 2020

Feb 08, 2021

SELL
$319.05 - $363.32 $708,291 - $806,570
-2,220 Reduced 48.26%
2,380 $865,000
Q3 2020

Oct 30, 2020

SELL
$280.08 - $347.78 $112,032 - $139,112
-400 Reduced 8.0%
4,600 $1.55 Million
Q3 2019

Nov 13, 2019

SELL
$294.25 - $341.49 $294,250 - $341,490
-1,000 Reduced 16.67%
5,000 $1.49 Million
Q3 2018

Nov 02, 2018

BUY
$236.3 - $277.15 $1.42 Million - $1.66 Million
6,000 New
6,000 $1.66 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $5.19B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Bp PLC Portfolio

Follow Bp PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

News

Stay updated on Bp PLC with notifications on news.